The complaint alleges nearly two dozen pharmaceutical companies colluded to limit competition, causing costs for certain generic medications to skyrocket.

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

Here are four large-cap value stocks that growth and income investors may want to consider now. History suggests they could rally this year.

The woman started experiencing the rapid growth one week after getting vaccinated in September 2022 — and it worsened after ...

You don't need a prescription to purchase a test that will tell you whether you're sick with COVID or the flu.

Cancer-focused CytomX Therapeutics Inc. will lay off 40% of its workforce — about 50 employees — to help extend its cash into ...

From condemning the Jan. 6 Capitol riots to helping fund the President-elect’s impending inauguration, recent years have seen ...

A small study published Monday found that the COVID-19 antiviral treatment Paxlovid may have use as a treatment for long ...

By Tom Loftus Kentucky Lantern Another $50,000 from tobacco giant Altria last month brings money raised to expand the ...

A patient-led study examines the potential of extended Paxlovid courses for Long COVID relief, documenting varied outcomes ...

By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.